Your position：Home > Exhibition & Communication

2023 Japan Cosmetic Raw Materials Exhibition (IN-PHARMA)

2023 Japan Cosmetic Raw Materials Exhibition (IN-PHARMA)

IN-PHARMA is an excellent platform for the largest and leading Asian raw material suppliers in the Japanese pharmaceutical industry to conduct business negotiations with the Japanese pharmaceutical industry. It is an important event that brings together key figures in the Japanese pharmaceutical market.
IN-PHARMA, the international exhibition specializing in pharmaceutical and cosmetic ingredients, is Asia's leading exhibition for pharmaceutical and cosmetic ingredients. By exhibiting at IN-PHARMA JAPAN, ingredient manufacturers can expand their sales and network in the pharmaceutical/cosmetic industry in Japan and Asia.

Exhibition Introduction
INTERPHEX Week Tokyo consists of the following 4 medical technology exhibitions. INTERPHEX JAPAN (Manufacturing & Packaging), in-Pharma Japan (Pharmaceutical Raw Materials), BioPharma Expo (Biopharmaceuticals), Pharma R&D Japan (Drug Development). As one of the largest pharmaceutical events in Asia, 1,900* exhibitors will gather at INTERPHEX Week Tokyo 2020. (*estimated)

Japan International Pharmaceutical Raw Materials and Ingredients Exhibition (in-PHARMA JAPAN) is an excellent platform for the largest Asian leading raw material suppliers in Japan's API industry to conduct business negotiations with the Japanese pharmaceutical industry, and it is an important event that brings together key figures in the Japanese pharmaceutical market. The exhibition is hosted by Reed Exhibitions Group, the world's largest exhibition organization, once a year. If you are a raw material supplier and want to expand your business in the Japanese market, participating in INTERPHEX JAPAN is a good choice.

Range of exhibition

Audience range
Exhibitors: 20,000 people, the number of exhibitors and participating brands reached 500.

Cosmetics manufacturer, semi-finished product manufacturer, custom synthetic compound manufacturer, original molecular designer general production, quality control, OTC manufacturer, research institution

Data of previous exhibitions
In November 2019, the Japan Medical Exhibition brought together 1,280 exhibitors from all over the world, 42,057 industry visitors came to the exhibition, and more than 3,000 overseas VIP purchases. The exhibition successfully invited 302 industry leaders to give speeches. Among them, leading figures from the Japanese pharmaceutical industry gather here.
Japan is the second largest pharmaceutical market in the world. Due to the increase in home care for the aging elderly and the growth of chronic diseases, the Japanese pharmaceutical market is expanding. The Japanese government strongly supports the development of the generic drug industry. The market share of Japanese generic drugs will reach 60%. Many Japanese pharmaceutical companies have increased their internal R&D budgets and expanded and strengthened external cooperation by developing product lines, establishing factories in emerging countries or contract processing outsourcing service CMOs. From 2014 to 2018, the Japanese pharmaceutical market grew rapidly, with an average annual growth rate of about 2.2%

Exhibition information

Exhibition time: July 05~07, 2023

Venue: Japan-Tokyo-3-21-1 Ariake, Koto-ku, Tokyo 135-0063, Japan-Tokyo Ariake 

International Convention and Exhibition Center --TOKYO BIG SIGHT

Exhibition area: 30,000 square meters

Sponsor: Reed Exhibitions (Japan) Co., Ltd. Reed Exhibition Japan Co.,Ltd
Holding cycle: once a year

Benepure is waiting for you in-PHARMA JAPAN！

BENEPURE is a leading manufacturing group company headquartered in Sichuan, China. Benepure has more than 15 years of experience in the production of plant extracts, specializing in the production of Citrus aurantium extracts/derivatives, Sophora japonica extracts/derivatives, polyphenols & anthocyanins series products, natural sweetener series products and other natural plant extracts It can be widely used in the fields of medicine, health, food, and cosmetics, and OEM services can also be provided according to customer requirements. All of our products are produced in accordance with GMP standards, and some products also provide DMF. Meanwhile, our products have been widely exported to more than 40 countries.

Benepure focuses on the following areas:

Citrus series products:
Hesperidin, Diosmin, Hesperidin Methylchalcone, Neohesperidin Dihydrochalcone, Citrus Flavonoids, Naringin, Neohesperidin, Citrus Aurantium Extract (Synephrine), Polymethoxylated Flavonoids (Pmf), Hesperetin, Hidrosmin, Naringenin, Naringin Dihydrochalcone, Methyl Hesperidin, Diosmetin, Nobiletin, Tangeretin, Lemon Flavonoids, Limonin, Luteolin, Apigenin

Sophora Japonica L. series products:
Rutin, Troxerutin, Quercetin, Isoquercetin, Rutin Water Soluble 


Natural Sweeteners:
Luo Han Guo Extract, Neohesperidin Dihydrochalcone, Stevia Leaf Extract, 
L-rhamnose Monahydrate

Polyphenol & Anthocyanin Series Products:
Apple Extract, Black Currant Extract, Cranberry Extract, Echinacea Purpurea Extract, Green Tea Extract, Grape Seed Extract, Pine Bark Extract, Lingonberry Extract

Other products:
Baicalin, Berberine HCL, Ginger Extract, Ginkgo Biloba Extract, Marigold Flower Extract (Lutein and Zeaxanthin), Olive Leaf Extract, Red Clover Extract, Resveratrol, Saw Palm Extract, Soy Isoflavone, Hypericum Perforatum Extract, Tribulus Terrestris Extract, Silymarin, Esculin

API：Ursodeoxycholic Acid、paclitaxel
Protected amino acid：F-Amino Acid, Boc-Amino Acid, Cbz-Amino Acid, etc.

1-10 in hall: 1 
Welcome to Benepure!



Previous：CPHI South East Asia 2023CPHI South East Asia 2023
Next：2020.12.16~12.18,CPHI China 2020, SNIEC, Shanghai, China, Booth No.:E3A98